Literature DB >> 20375545

Toll-like receptor responses in IRAK-4-deficient neutrophils.

Robin van Bruggen1, Agata Drewniak, Anton T J Tool, Machiel Jansen, Michel van Houdt, Judy Geissler, Timo K van den Berg, Helen Chapel, Taco W Kuijpers.   

Abstract

Human neutrophils were found to express all known Toll-like receptors (TLRs) except TLR3 and TLR7. IRAK-4-deficient neutrophils were tested for their responsiveness to various TLR ligands. Essentially all TLR responses in neutrophils, including the induction of reactive oxygen species generation, adhesion, chemotaxis and IL-8 secretion, were found to be dependent on IRAK-4. Surprisingly, the reactivity towards certain established TLR ligands, imiquimod and ODN-CpG, was unaffected by IRAK-4 deficiency, demonstrating their activity is independent of TLR. TLR-4-dependent signaling in neutrophils was totally dependent on IRAK-4 without any major TRIF-mediated contribution. We did not observe any defects in killing capacity of IRAK-4-deficient neutrophils for Staphylococcus aureus, Escherichia coli and Candida albicans, suggesting that microbial killing is primarily TLR independent. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20375545     DOI: 10.1159/000268288

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  16 in total

Review 1.  Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.

Authors:  Capucine Picard; Jean-Laurent Casanova; Anne Puel
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

2.  Human TLR8 is activated upon recognition of Borrelia burgdorferi RNA in the phagosome of human monocytes.

Authors:  Jorge L Cervantes; Carson J La Vake; Bennett Weinerman; Stephanie Luu; Caitlin O'Connell; Paulo H Verardi; Juan C Salazar
Journal:  J Leukoc Biol       Date:  2013-08-01       Impact factor: 4.962

3.  Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair.

Authors:  Cathelijn E M Aarts; Ida H Hiemstra; Eelke P Béguin; Arjan J Hoogendijk; Souhailla Bouchmal; Michel van Houdt; Anton T J Tool; Erik Mul; Machiel H Jansen; Hans Janssen; Floris P J van Alphen; Jan-Paul de Boer; Charlotte L Zuur; Alexander B Meijer; Timo K van den Berg; Taco W Kuijpers
Journal:  Blood Adv       Date:  2019-11-26

4.  Protective effect of diallyl trisulfide on liver in rats with sepsis and the mechanism.

Authors:  Huawen Chen; Wei Zhu; Jun Feng; Shusheng Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10

Review 5.  Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils.

Authors:  Ashley A Stegelmeier; Maedeh Darzianiazizi; Kiersten Hanada; Shayan Sharif; Sarah K Wootton; Byram W Bridle; Khalil Karimi
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 6.  Educational paper: Defects in number and function of neutrophilic granulocytes causing primary immunodeficiency.

Authors:  J Merlijn van den Berg; Taco W Kuijpers
Journal:  Eur J Pediatr       Date:  2011-10-04       Impact factor: 3.183

Review 7.  Host response to Candida albicans bloodstream infection and sepsis.

Authors:  Seána Duggan; Ines Leonhardt; Kerstin Hünniger; Oliver Kurzai
Journal:  Virulence       Date:  2015-03-18       Impact factor: 5.882

Review 8.  Neutrophil cell surface receptors and their intracellular signal transduction pathways.

Authors:  Krisztina Futosi; Szabina Fodor; Attila Mócsai
Journal:  Int Immunopharmacol       Date:  2013-08-30       Impact factor: 4.932

Review 9.  Neutrophil-derived cytokines: facts beyond expression.

Authors:  Cristina Tecchio; Alessandra Micheletti; Marco A Cassatella
Journal:  Front Immunol       Date:  2014-10-21       Impact factor: 7.561

Review 10.  Neutrophils: Between host defence, immune modulation, and tissue injury.

Authors:  Philipp Kruger; Mona Saffarzadeh; Alexander N R Weber; Nikolaus Rieber; Markus Radsak; Horst von Bernuth; Charaf Benarafa; Dirk Roos; Julia Skokowa; Dominik Hartl
Journal:  PLoS Pathog       Date:  2015-03-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.